Opportunities and outcomes in early prostate cancer: A commentary on policy, patient perspectives, trials and strategies

BJU International

Volumn 91, Issue 3, 2003, Pages 177-178

  Feneley, M R ^a   Brewster, S ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE; AGED; AUSTRIA; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURAL FACTOR; DECISION MAKING; EARLY DIAGNOSIS; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; LIFE EXPECTANCY; MALE; MASS SCREENING; METASTASIS; MORTALITY; NOTE; OBSERVATION; PATIENT INFORMATION; PERCEPTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PUBLICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

AGED; CLINICAL TRIALS; HEALTH POLICY; HUMANS; MALE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 0037329491     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04068.x     Document Type: Note

References (15)

1. Thornton H, Dixon-Woods M. Prostate specific antigen testing for prostate cancer. BMJ 2002; 325: 725-6
2. Chapple A, Ziebland S, Shepperd S, Miller R, Herxheimer A, McPherson A. Why men with prostate cancer want wider access to prostate specific antigen testing: qualitative study. BMJ 2002; 325: 737-9
3. Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ 2002; 325: 740-3
4. Holmberg L, Bill-Axelson A, Helgesen F et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781-9
5. Steineck G, Helgesen F, Adolfsson J et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002; 347: 790-6
6. NHS Cancer Screening Programmes. The Prostate Cancer Risk Management Programme. 2002 http://www.cancerscreening.nhs.uk/prostate/index.html
7. Burack RC, Wood DPJ. Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness. Med North Am 1999; 83: 1423-42
8. Potosky AL, Feuer EJ, Levin DL. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev 2001; 23: 181-6
9. Bartsch G, Horninger W, Klocker H et al. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol. Austria Urol 2001; 58: 417-24
10. Schroder FH, Kranse R, Rietbergen J, Hoedemaeke R, Kirkels W. The European Randomized Study of Screening for Prostate Cancer [ERSPC): an update. Eur Urol 1999; 35: 539-43
11. Prorok PC, Andriole GL, Bresalier RS et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21 (Suppl. 6): 273S-309S
12. de Koning HJ, Auvinen A, Berenguer SA et al. Large-scale randomized prostate cancer screening trials. Program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002; 97: 237-44
13. Donovan J, Mills N, Smith M et al. Quality improvement report. Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult. BMJ 2002; 325: 766-70
14. Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol 1994; 152: 1910-4
15. Thompson IMJ, Kouril M, Klein EA, Coltman CA, Ryan A, Goodman P. The Prostate Cancer Prevention Trial. Current status and lessons learned. Urology 2001; 57 (Suppl. 1): 230-4